Login / Signup

Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.

Danilo Di BonaAndrea MinielloEustachio Nettis
Published in: Clinical and molecular allergy : CMA (2022)
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.
Keyphrases
  • adverse drug
  • sars cov
  • drug induced
  • coronavirus disease
  • electronic health record
  • systematic review
  • emergency department
  • respiratory syndrome coronavirus
  • soft tissue
  • wound healing
  • high density
  • single cell